NIH-ural selection

Eric Hand had an article on Nature.com yesterday about trends in post-doubling NIH grants. I don't agree that giving prominent PIs disproportionately large numbers of grants is automatically a bad thing - it depends on the size of the lab's staff and how productive/important their research strategy, among other concerns. But I was interested by this (emphasis mine):

Zerhouni says that the inequities between the haves and have-nots were caused by a doubling of NIH funding between 1998 and 2003. As funding levels rose, many new PhD positions were created. Established investigators, using data produced by the new PhDs, were able to submit better grant proposals. But hordes of these grant-hungry PhDs were left standing when NIH funding flattened out after 2003. The agency now funds significantly more people over the age of 70 than under the age of 30. "We're eating our seedcorn," says Zerhouni.

I graduated in 2003. No comment. . .

More like this

As an NIH-funded surgeon/scientist, I just had to read this report at BrokenPipeline.org when I became aware of it, courtesy of Bora and Drugmonkey. Basically, it describes how bleak the NIH funding situation has become, particularly for young investigators. The report (PDF) comes from several…
Excellent analysis from an article in Science on the recent funding woes (sadly behind a subscription wall). Money quote: Meanwhile, research institutions everywhere were breaking ground on new facilities and expanding their faculty. In a 2002 survey, AAMC found that new construction at medical…
In keeping with the Broken Pipeline theme (see ScienceBloglings Greg, Coturnix, and Drug Monkey), this letter to Sen. Evan Bayh (D-IN) from the Coalition for the Life Sciences about his efforts to shift more funding to the Small Business Innovation Research (SBIR) and the Small Business Technology…
by revere [Since my colleague and new blog sibling Dave Ozonoff posted here some advice on NIH grant writing in response to a post of mine over at Effect Measure, I thought I'd cross-post a follow-up I did on NIH funding a few days later. BTW, Dave, I'll have to give you some lessons in snarkiness…